14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for HROW

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.20 7.35 %
R2 10.90 4.53 %
R1 10.72 2.79 %
Current price: 10.43
Support S1 10.13 -2.85 %
S2 9.95 -4.59 %
S3 9.66 -7.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.50 10.26 %
R2 10.58 1.44 %
R1 10.52 0.86 %
Current price 10.43
Support S1 10.32 -1.05%
S2 10.00 -4.12%
S3 9.95 -4.60%

HROW Predictions History

5 years ago
StockVader predicted that HROW for 2019-02-15 is going $6.19 (0.49%)

5 years ago
PumpTheseNumbers predicted that HROW for 2019-02-15 is going $6.20 (0.65%)

5 years ago
JS predicted that HROW for 2019-01-08 is going $5.55 (2.97%)

5 years ago
SAM predicted that HROW for 2019-01-08 is going $5.53 (2.60%)

Rank:

5 years ago
JS predicted that HROW for 2018-10-29 is going $4.00 (-0.99%)

5 years ago
Swingtrader2020 predicted that HROW for 2018-10-29 is going $2.08 (-48.51%)

Rank:

7 years ago
Kayr.Thomas.5370 predicted that HROW for 2017-04-06 is going $1.92 (-48.80%)

Rank:

7 years ago
JS predicted that HROW for 2016-12-28 is going $2.70 (10.66%)

7 years ago
Christopher.Michael.Perdigao.1751 predicted that HROW for 2016-12-28 is going $3.00 (7.91%)

Rank:
Click to get the best stock tips daily for free!

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma... HROW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT